Epigenetic modifiers exacerbate oxidative stress in renal proximal tubule cells

Anticancer Research

Volumn 29, Issue 6, 2009, Pages 2295-2299

  Nadasi, Edit ^a   Clark, Jeb S ^b   Szanyi, Istvan ^c   Varjas, Timea ^d   Ember, Istvan ^d   Baliga, Radhakrishna ^b   Arany, Istvan ^b  

^a IQVIA   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PÉCS   (Hungary)

^d UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Cancer; Mitochondria; Nephrotoxicity; ROS; Therapy

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ACETYLCYSTEINE; ANTINEOPLASTIC AGENT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; TRICHOSTATIN A;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; ENZYME RELEASE; EPIGENETICS; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOUSE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBIOTICS, ANTIFUNGAL; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; CELL SURVIVAL; CELLS, CULTURED; HYDROXAMIC ACIDS; KIDNEY TUBULES, PROXIMAL; MICE; REACTIVE OXYGEN SPECIES;

EID: 67650912108     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Herranz M and Esteller M: New therapeutic targets in cancer: the epigenetic connection. Clin Transl Oncol 8: 242-249, 2006.
2. Robertson KD and Jones PA: DNA methylation: past, present and future directions. Carcinogenesis 21: 461-467, 2000. (Pubitemid 30137931)
3. Orr JA and Hamilton PW: Histone acetylation and chromatin pattern in cancer. A review. Anal Quant Cytol Histol 29: 17-31, 2007. (Pubitemid 46333518)
4. Palii SS and Robertson KD: Epigenetic control of tumor suppression. Crit Rev Eukaryot Gene Expr 17: 295-316, 2007.
5. Carew JS, Giles FJ and Nawrocki ST: Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy. Cancer Lett 269: 7-17, 2008.
6. Murgo AJ: Innovative approaches to the clinical development of DNA methylation inhibitors as epigenetic remodeling drugs. Semin Oncol 32: 458-464, 2005. (Pubitemid 41396422)
7. Zhu WG and Otterson GA: The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells. Curr Med Chem Anticancer Agents 3: 187-199, 2003. (Pubitemid 36512029)
8. Kintzel PE: Anticancer drug-induced kidney disorders. Drug Saf 24: 19-38, 2001.
9. Ries F and Klastersky J: Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis 8: 368-379, 1986. (Pubitemid 17235084)
10. Peterson BA, Collins AJ, Vogelzang NJ and Bloomfield CD: 5-Azacytidine and renal tubular dysfunction. Blood 57: 182-185, 1981.
11. Peterson BA, Bloomfield CD, Gottlieb AJ, Coleman M and Greenberg MS: 5-Azactidine and zorubicin for patients with previously treated acute nonlymphocytic leukemia: a Cancer and Leukemia Group B pilot study. Cancer Treat Rep 66: 563-566, 1982. (Pubitemid 12084954)
12. Dong G, Wang L, Wang CY, Yang T, Kumar MV and Dong Z: Induction of apoptosis in renal tubular cells by histone deacetylase inhibitors, a family of anticancer agents. J Pharmacol Exp Ther 325: 978-984, 2008. (Pubitemid 351724333)
13. Lau AT, Wang Y and Chiu JF: Reactive oxygen species: current knowledge and applications in cancer research and therapeutic. J Cell Biochem 104: 657-667, 2008. (Pubitemid 351671652)
14. Xu WS, Parmigiani RB and Marks PA: Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 26: 5541-5552, 2007. (Pubitemid 47255934)
15. Gao S, Mobley A, Miller C, Boklan J and Chandra J: Potentiation of reactive oxygen species is a marker for synergistic cytotoxicity of MS-275 and 5-azacytidine in leukemic cells. Leuk Res 32: 771-780, 2008. (Pubitemid 351323931)
16. Sutton TA and Molitoris BA: Mechanisms of cellular injury in ischemic acute renal failure. Seminars in Nephrology 18: 490-497, 1998. (Pubitemid 28430752)
17. Ushio-Fukai M and Nakamura Y: Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 266: 37-52, 2008. (Pubitemid 351753035)
18. Storz P: Reactive oxygen species in tumor progression. Front Biosci 10: 1881-1896, 2005.
19. Droge W: Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002. (Pubitemid 34654215)
20. Ernest S and Bello-Reuss E: Expression and function of P-glycoprotein in a mouse kidney cell line. Am J Physiol 269: C323-333, 1995.
21. Arany I, Faisal A, Nagamine Y and Safirstein RL: p66shc Inhibits pro-survival epidermal growth factor receptor/ERK signaling during severe oxidative stress in mouse renal proximal tubule cells. J Biol Chem 283: 6110-6117, 2008.
22. 2 cytotoxicity in mouse renal proximal tubule cells. Kidney Int 65: 1231-1239, 2004. (Pubitemid 38406961)
23. Wang H and Joseph JA: Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 27: 612-616, 1999. (Pubitemid 29408648)
24. Arany I, Grattendick KG and Tyring SK: Interleukin-10 induces transcription of the early promoter of human papillomavirus type 16 (HPV16) through the 5′-segment of the upstream regulatory region (URR). Antiviral Research 55: 331-339, 2002.
25. Martindale JL and Holbrook NJ: Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192: 1-15, 2002. (Pubitemid 34587382)
26. Arany I, Megyesi JK, Reusch JE and Safirstein RL: CREB mediates ERK-induced survival of mouse renal tubular cells after oxidant stress. Kidney Int 68: 1573-1582, 2005. (Pubitemid 43169902)
27. Flombaum CD: Acute renal failure and dialysis in cancer patients. Crit Care Clin 4: 61-79, 1988. (Pubitemid 18135803)
28. Baliga R, Ueda N, Walker PD and Shah SV: Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev 31: 971-997, 1999.
29. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, Crowe RA, Cascio WE, Bradham CA, Brenner DA and Herman B: The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1366: 177-196, 1998. (Pubitemid 28467031)
30. Giorgio M, Trinei M, Migliaccio E and Pelicci PG: Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? Nat Rev Mol Cell Biol 8: 722-728, 2007.
31. Ventura A, Luzi L, Pacini S, Baldari CT and Pelicci PG: The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter. J Biol Chem 277: 22370-22376, 2002. (Pubitemid 34967205)
32. Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi PP, Lanfrancone L and Pelicci PG: The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402: 309-313, 1999. (Pubitemid 129516269)
33. Pellegrini M, Pacini S and Baldari CT: p66SHC: The apoptotic side of She proteins. Apoptosis 10: 13-18, 2005. (Pubitemid 40558111)